Terms: = Thyroid cancer AND PR, PGR, progesterone receptor AND Staging
9 results:
1. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
[No Abstract] [Full Text] [Related]
2. Clinical characteristics and prognosis of primary small cell carcinoma of the breast: a propensity score-matched, population-based study.
Yin L; Yin AH; Pu CC
BMJ Open; 2023 Dec; 13(12):e073841. PubMed ID: 38097248
[TBL] [Abstract] [Full Text] [Related]
3. Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast cancers and thyroid Disease.
Li J; Liu Y; Jin J; Shi Q; Ji Y; Zhang B; Hu P
Mediators Inflamm; 2023; 2023():3133554. PubMed ID: 37152372
[TBL] [Abstract] [Full Text] [Related]
4. [Multicenter real-world study on safety and efficacy of neoadjuvant therapy in combination with immunotherapy for colorectal cancer].
Liu XZ; Xiong Z; Xiao BY; Yu GY; Li YJ; Yao YF; Tao KX; Ding PR; Zhang W; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):219-227. PubMed ID: 35340171
[No Abstract] [Full Text] [Related]
5. Changes of breast cancer staging when AJCC prognostic staging manual is used: a retrospective analysis of a Chinese cohort.
Ding J; Wu W; Fang J; Chu Y; Zheng S; Jiang L
Int J Biol Markers; 2018 May; 33(2):168-173. PubMed ID: 28967067
[TBL] [Abstract] [Full Text] [Related]
6. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
[TBL] [Abstract] [Full Text] [Related]
7. Metastatic large cell neuroendocrine carcinoma of the lung arising from the uterus: A pitfall in lung cancer diagnosis.
Ono K; Yokota NR; Yoshioka E; Noguchi A; Washimi K; Kawachi K; Miyagi Y; Kato H; Yokose T
Pathol Res Pract; 2016 Jul; 212(7):654-7. PubMed ID: 27113439
[TBL] [Abstract] [Full Text] [Related]
8. Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas.
Müssig K; Wehrmann T; Dittmann H; Wehrmann M; Ueberberg B; Schulz S; Bares R; Petersenn S
Clin Endocrinol (Oxf); 2012 Jul; 77(1):139-45. PubMed ID: 22248072
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
[TBL] [Abstract] [Full Text] [Related]
